Your browser doesn't support javascript.
loading
Clinical Trial Drug Safety Assessment for Studies and Submissions Impacted by COVID-19.
Nilsson, Mary; Crowe, Brenda; Anglin, Greg; Ball, Greg; Munsaka, Melvin; Shahin, Seta; Wang, Wei.
Affiliation
  • Nilsson M; Eli Lilly and Company, Indianapolis, IN.
  • Crowe B; Eli Lilly and Company, Indianapolis, IN.
  • Anglin G; Eli Lilly Canada Inc., Toronto, ON, Canada.
  • Ball G; Merck & Co., Inc., Rahway, NJ.
  • Munsaka M; AbbVie Inc., North Chicago, IL.
  • Shahin S; Amgen Inc., Thousand Oaks, CA.
  • Wang W; Eli Lilly Canada Inc., Toronto, ON, Canada.
Stat Biopharm Res ; 12(4): 498-505, 2020 Sep 08.
Article in En | MEDLINE | ID: mdl-34191982
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline Language: En Journal: Stat Biopharm Res Year: 2020 Document type: Article Affiliation country: India Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline Language: En Journal: Stat Biopharm Res Year: 2020 Document type: Article Affiliation country: India Country of publication: United States